Frontlight ResearchEarly access
Trial site
Tokuyama Clinic
- 4running trials
- 6closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes10 trials
- Obesity5 trials
- Type 1 diabetes1 trial
- Phase
- Phase 39 trials
- Phase 21 trial
- Status
- Completed5 trials
- Active, not recruiting3 trials
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Eli Lilly and Company10 trials
Running trials
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Active, not recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Withdrawn
Completed
Completed
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026